Release of platelet‐activating factor (PAF‐acether) from alveolar macrophages by the calcium ionophore A 23187 and phagocytosis

No abstract is available for this paper.

• Publication year

  1980

• Venue

  European Journal of Clinical Investigation

• Publication date

  1980-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1365-2362.1980.tb02082.xPMID 6788561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Release, purification, and characterization of platelet-activating factor (PAF).

  1980cited by this paper
• Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

  1980cited by this paper
• Human neutrophil-derived platelet activating factor.

  1980cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979cited by this paper
• The role of platelet-activating factor in platelet aggregation

  1979cited by this paper
• Slow reacting substance (SRS) from ionophore A23187-stimulated peritoneal mast cells of the normal rat. I. Conditions of generation and initial characterization.

  1979cited by this paper
• Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes

  1979cited by this paper
• Semi-synthèse et structure proposée du facteur activant les plaquettes (P.A.F.): PAF-acether, un alkyl ether analogue de la lysophosphatidylcholine.

  1979cited by this paper
• Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes.

  1978cited by this paper
• Pharmacological control of prostaglandin and thromboxane release from macrophages

  1978cited by this paper
• Ionophore A 23187-induced production of slow reacting substance of anaphylaxis (SRS-A) by rat peritoneal cells in vitro: evidence for production by mononuclear cells.

  1978cited by this paper
• Structural analysis of purified platelet-activating factor by lipases

  1977cited by this paper
• Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils.

  1977cited by this paper
• Pulmonary macrophage and epithelial cells

  1977cited by this paper
• Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion.

  1977cited by this paper
• A molecular concept of the properdin pathway.

  1976cited by this paper
• Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187.

  1976cited by this paper
• Evidence for the involvement of IgE-basophil system in acute serum sickness.

  1976cited by this paper
• IgE-induced release of a platelet-activating factor from rabbit lung.

  1975cited by this paper
• Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis

  1975cited by this paper
• Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils

  1974cited by this paper
• Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.

  1973cited by this paper
• LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS

  1972cited by this paper
• Platelet function in health and disease.

  1971cited by this paper
• ACUTE IMMUNE COMPLEX DISEASE IN RABBITS

  1971cited by this paper
• Destruction of rabbit platelets in the allergic response of sensitized leukocytes. II. Evidence for basophil involvement.

  1971cited by this paper
• Destruction of rabbit platelets in the allergic response of sensitized leukocytes. I. Demonstration of a fluid phase intermediate.

  1971cited by this paper
• The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.

  1971cited by this paper
• Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic releas of histamine an slow-reacting substance of anaphylaxis (SRS-A).

  1970cited by this paper
• Immunochemical and Biologic Properties of Rat IgE

  1970cited by this paper
• A study of macrophages and epitheloid-like cells from granulomatous (BCG-induced) lungs of rabbits.

  1962cited by this paper

• Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome

  2023cites this paper
• The Definition of Emphysema

  2015cites this paper
• Decreased suppressor cell activity of alveolar macrophages in bronchial asthma.

  2015cites this paper
• LIPID MEDIATORS IN OCULAR INFLAMMATORY MODELS

  2013cites this paper
• Nedocromil Sodium Inhibition of IgE-Mediated Activation of Human Mononuclear Phagocytes and Platelets from Asthmatics

  2012cites this paper
• Asthma-What Are the Important Experiments?

  2012cites this paper
• Rôle des cellules Natural Killer dans l'asthme allergique

  2010cites this paper
• The role of eosinophils in asthma

  2007cites this paper
• Acute Lung Infammation Induced in the Rabbit by Local Instillation of 1 -0-Octadecyl-2-acetyl-sn-glyceryl-3-phosphorycho line or of Native Platelet-Activating Factor

  2007cites this paper
• Role of the polymorphonuclear leukocyte: Interaction with nosocomial pathogens

  2005cites this paper
• Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation

  2005influential citation
• Lung inflammation, its significance for asthma therapy

  2005cites this paper
• Inflammatory cells in asthma: mechanisms and implications for therapy.

  2003cites this paper
• Pathophysiology of asthma.

  2003cites this paper
• Platelet function and coronary artery disease

  2001cites this paper
• Effects of BN-50730 (PAF receptor antagonist) and physostigmine (AChE inhibitor) on learning and memory in mice.

  1997cites this paper
• Pathological Aspects of Platelet-Activating Factor (PAF)

  1997cites this paper
• Platelet-activating factor contributes to immune cell and oxidant-mediated intestinal secretion.

  1997cites this paper
• Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Glucocorticosteroids, old and new: Biological function and use in the treatment of asthma

  1996cites this paper
• Effects of Platelet Activating Factor on Mucociliary Clearance of the Eustachian Tube

  1996cites this paper
• Platelet-Activating Factor and PAF-Like Mimetics

  1996cites this paper
• Role of macrophages in pulmonary late-phase reaction in guinea pigs.

  1996cites this paper
• Decrease of ciliary beat frequency by platelet activating factor: Protective effect of ketotifen

  1996cites this paper
• PAF and Antigen-Induced Bronchial Hyperreactivity in Guinea Pigs

  1996cites this paper
• Lipid Second Messengers

  1996cites this paper
• Regulation of platelet‐activating factor production in gastric epithelial cells

  1996cites this paper
• Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.

  1995cites this paper
• The Mononuclear Phagocyte

  1995cites this paper
• The Effect of Platelet Activating Factor (PAF) on Mucociliary Transport of the Eustachian Tube

  1995cites this paper
• Platelet-activating factor stimulates gastric acid secretion in isolated rabbit gastric glands.

  1995cites this paper
• Platelet-Activating Factor

  1995cites this paper
• Mononuclear cells in the pathogenesis of bronchial asthma

  1995cites this paper
• Cyclic AMP enhancing drugs modulate eicosanoid release from human alveolar macrophages.

  1994cites this paper
• 8 – Biological Properties of Platelet-Activating Factor

  1994cites this paper
• The production of platelet activating factor (PAF) from neutrophils in bronchial asthmatics

  1994cites this paper
• Bimodal effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.

  1994cites this paper
• 7 – Cellular Sources of Platelet-Activating Factor and Related Lipids

  1994cites this paper
• Effect of platelet-activating factor on intracellular free calcium in cow tracheal epithelium.

  1994cites this paper
• Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.

  1993cites this paper
• Study on the metabolism of lyso-platelet activating factor (lyso-PAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF.

  1993cites this paper
• Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo

  1993cites this paper
• Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy.

  1993cites this paper
• Cells and Mediators Involved in Airway Hyperresponsiveness

  1993cites this paper
• Daño pulmonar difuso en la rata por la administración endovenosa del factor activador plaquetario

  1993cites this paper
• The role of macrophages in the mechanisms of airway inflammation in asthma.

  1992cites this paper
• Stimulation of cyclic AMP production in human alveolar macrophages induced by inflammatory mediators and beta-sympathicomimetics.

  1992cites this paper
• Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat.

  1992cites this paper
• Porins and lipopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells.

  1992cites this paper
• Effects of single and multiple inhalations of platelet‐activating factor on airway cell composition and responsiveness in monkeys

  1992cites this paper
• Platelet-activating factor causes neutrophil accumulation and neutrophil-mediated increased vascular permeability in canine trachea.

  1992cites this paper
• Cytokines, platelet activating factor and eosinophils in asthma.

  1992cites this paper
• Platelet-activating factor production during hemodialysis: effect of BN 52021.

  1992cites this paper
• Platelet-activating factor primes human eosinophil generation of superoxide.

  1992cites this paper
• Inflammation and airway reactivity in asthma.

  1992cites this paper
• PAF and the role of the vagus nerve in the breathing pattern of the pig.

  1992cites this paper
• Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation.

  1992cites this paper
• Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors.

  1992cites this paper
• Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers.

  1992cites this paper
• Platelet-activating factor in cardiovascular stress situations

  1991cites this paper
• Protein kinase C regulates the synthesis of platelet-activating factor by human monocytes.

  1991cites this paper
• Interactions between macrophages and granulocytes in bronchial asthma.

  1991cites this paper
• The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils.

  1991cites this paper
• Pulmonary Function in Mechanically Ventilated Patients

  1991cites this paper
• Effect of differentiation on platelet-activating factor metabolism in HL-60 cells.

  1991cites this paper
• Evidence for a platelet-activating factor receptor on human alveolar macrophages.

  1991cites this paper
• Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys.

  1991cites this paper
• Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung

  1991cites this paper
• Chronic Asthma in the Adult: Pathogenesis and Pharmacotherapy

  1991cites this paper
• Neutrophil chemotactic activity of PAF, histamine and neuromediators in bronchial asthma.

  1991cites this paper
• Activation mechanisms of platelet-activating factor in U937 cells: possible involvement of protein kinase C.

  1991cites this paper
• Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.

  1991cites this paper
• Platelet activating factor induced respiratory mucosal damage

  1991cites this paper
• Platelet-activating Factor

  1991cites this paper
• Cell-Cell Interactions in the Release of Inflammatory Mediators

  1991cites this paper
• Mucosal inflammation in asthma.

  1990cites this paper
• La réaction bronchique retardée ou non immédiate

  1990cites this paper
• Platelet-activating factor-induced aggregation of rat alveolar macrophages.

  1990cites this paper
• Immunologic Reactions in Asthma

  1990cites this paper
• Macrophage‐granulocyte interactions in allergic diseases

  1990cites this paper
• Mucosal dysfunction and damage induced by platelet activating factor (PAF).

  1990cites this paper
• Eosinophil accumulation in pulmonary airways of guinea‐pigs induced by exposure to an aerosol of platelet‐activating factor: effect of anti‐asthma drugs

  1990cites this paper
• Platelet-activating factor (PAF) and PAF antagonists in asthma.

  1990cites this paper
• Macrophages and polymorphonuclear neutrophils in lung defense and injury.

  1990cites this paper
• Bronchoalveolar lavage in allergic asthma.

  1990cites this paper
• Comparison of the generation of platelet-activating factor and leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and by the calcium ionophore A23187: the effects of nedocromil sodium.

  1990cites this paper
• The effect of platelet-activating factor on histamine release from rat peritoneal mast cells.

  1990cites this paper
• PAF metabolism in resident and activated alveolar macrophages: role of protein kinase C.

  1990cites this paper
• Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects.

  1990cites this paper
• Prophylactic treatment with an aerosolized corticosteroid liposome in a porcine model of early ARDS induced by endotoxaemia.

  1990cites this paper
• [Inhibitory effect of dauricine on platelet activating factor released from calcimycin-induced mouse peritoneal macrophages].

  1990cites this paper
• Tumor necrosis factor primes the effects of platelet-activating factor on rat vascular permeability.

  1990cites this paper
• The Role of Lung Mononuclear Cells in Asthma

  1990cites this paper
• Preclinical and clinical pharmacology of platelet‐activating factor receptor antagonists

  1990cites this paper
• Generation of platelet activating factor (PAF) by a human lung epithelial cell line.

  1990cites this paper
• [Platelet activating factor--a biologically active phospholipid].

  1990cites this paper
• Acute and long‐term pulmonary effects of platelet‐activating factor

  1989cites this paper
• Intravital microscopic studies on acute mast cell-dependent inflammation.

  1989cites this paper
• Platelet-activating factor and airway reactivity.

  1989cites this paper
• Clinical Significance of Anti-IgE Autoantibodies and Immune Complexes Containing IgE

  1989cites this paper
• Platelet activating factor in pulmonary pathobiology.

  1989cites this paper